February 05, 2018 Tim McCarthy, Chairman of Immupharma discusses the completion of Lupuzor™ pivotal phase III study and initiation of follow up study. Read More January 15, 2018 Small Company Share Watch – Jan 2018… Read More October 04, 2017 Q&A with Tim McCarthy Non-Executive Chairman at ImmuPharma PLC (LON:IMM) Read More September 28, 2017 On the right track – Sept 2017 Read More May 30, 2017 Business insights from Small Cap Leaders – May 2017 Read More April 13, 2017 Why Lupus Treatment is a potential game-changer – April 2017 Read More April 10, 2017 All Street Cap – April 2017 Read More August 25, 2016 Healthcare Heroes – Shares magazine, August 2016 Read More July 07, 2016 Northland Capital Partners ImmuPharma Initiation VA – July 2016 Read More July 01, 2016 AIM Journal – July 2016 Read More June 08, 2016 Lupus news today – June 2016 Read More March 08, 2016 Growth Company Investor – March 2016 Read More 1234
February 05, 2018 Tim McCarthy, Chairman of Immupharma discusses the completion of Lupuzor™ pivotal phase III study and initiation of follow up study. Read More
